Welcome to our dedicated page for Ametek SEC filings (Ticker: AME), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AMETEK, Inc. (NYSE: AME) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. AMETEK’s common stock is registered under Section 12(b) of the Securities Exchange Act of 1934 and is listed on the New York Stock Exchange under the trading symbol AME, as confirmed in multiple Form 8-K reports.
Among the key filings available are Form 8-K current reports, which AMETEK uses to announce material events. Recent examples include 8-K filings reporting quarterly financial results under Item 2.02, where the company furnishes press releases detailing net sales, operating income, segment performance for the Electronic Instruments Group and Electromechanical Group, and reconciliations of GAAP to non-GAAP measures such as adjusted operating income and adjusted diluted earnings per share. Other 8-K filings disclose events under Item 5.02, such as the planned retirement of a senior vice president and principal accounting officer and the election of a successor, and under Item 8.01 for events like the completion of the FARO Technologies acquisition.
Filings also include a Form 15 relating to the termination or suspension of reporting obligations for plan interests in the Superior Tube Company, Inc. Union 401(k) Plan following its merger into the AMETEK Retirement and Savings Plan. This document clarifies that AMETEK, Inc. common stock remains a class of securities for which reporting duties continue.
On Stock Titan, AME filings are updated as they are released on EDGAR, and AI-powered summaries can help explain the context and key points in lengthy documents. Users can review current reports for earnings announcements, management changes, and acquisition completions, as well as specialized filings like Form 15 related to benefit plans. This page supports investors who want to understand how AMETEK communicates financial performance, governance changes, and corporate actions through its official SEC reporting.
AMETEK executive Tony J. Ciampitti, President of Electronic Instruments, received new equity awards. He was granted stock options for 4,110 shares of common stock at an exercise price of $212.77 per share, which become exercisable in three equal annual installments beginning on March 18, 2027. He also received 1,300 shares of restricted common stock valued at $212.77 per share, while 229 shares were withheld to pay taxes. Following these transactions, he directly holds 56,189 shares of common stock, plus 4,110 stock options, with additional holdings of 9,465 units in a SERP account and 2,776 shares through a 401(k) plan.
Oberton Karleen Marie reported acquisition or exercise transactions in this Form 4 filing.
AMETEK Inc. director Karleen Marie Oberton received a grant of 950 shares of Common Stock, constituting restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. The award was valued at $212.77 per share on the grant date. Following this grant, she directly holds 5,640 shares.
AMATO THOMAS A reported acquisition or exercise transactions in this Form 4 filing.
AMETEK director Thomas A. Amato received a grant of 950 shares of restricted common stock, valued at $212.77 per share, under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. This is a compensation-related award rather than an open-market purchase.
After the grant, he directly holds 5,010 common shares. The filing also shows an additional 6,500 common shares held indirectly by a trust, giving him both direct and indirect exposure to AMETEK stock.
AMETEK Inc. director Stefany Suzanne received a grant of 950 shares of Common Stock as a restricted stock award. The award was issued at a value of $212.77 per share under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Following this compensation-related acquisition, she directly holds 5,030 AMETEK shares.
AMETEK Inc. director Dean Seavers reported an equity award of company stock. On this Form 4, he acquired 950 shares of AMETEK common stock as a grant or award valued at $212.77 per share. The shares constitute restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.
Following this award, Seavers directly holds 5,600 shares of AMETEK common stock. This transaction reflects compensation in stock rather than an open-market purchase.
AMETEK director Anthony James Conti received a grant of company stock as compensation. He acquired 950 shares of AMETEK common stock on March 18, 2026, recorded at $212.77 per share, as restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Following this award, he directly owns 30,298 common shares. This was a compensation-related grant, not an open-market purchase.
Carpenter Tod E. reported acquisition or exercise transactions in this Form 4 filing.
AMETEK director Tod E. Carpenter received a grant of 950 shares of common stock, valued at $212.77 per share, as equity compensation. The award is restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan and is held directly.
After this grant, Carpenter directly owns 10,480 AMETEK common shares. Restricted stock generally vests over time or upon meeting conditions, aligning a director’s interests with long-term shareholder value rather than representing an open-market purchase.
AMETEK director Gretchen W. McClain received 950 shares of common stock as a restricted stock award at $212.77 per share under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. This is a compensation-related grant, not an open‑market purchase.
McClain now holds 18,981 shares of common stock directly after this award. She also acquired 52 additional common stock units through dividend reinvestments in the Deferred Compensation Plan, bringing her deferred compensation holdings to 3,199 units. These transactions reflect routine equity compensation and plan reinvestments rather than discretionary trading.
AMETEK, Inc. is asking stockholders to vote at its virtual 2026 annual meeting on May 7, 2026. Holders of 229,065,429 shares of common stock as of March 9, 2026 may vote on three proposals: electing three Class II directors, an advisory “say‑on‑pay” vote, and ratifying Ernst & Young LLP as independent auditor for 2026.
The Board is largely independent, uses majority voting in uncontested director elections, and highlights strong historic support for its pay and audit practices, with about 94% average approval on executive compensation over the past decade and 93% support for Ernst & Young in the prior year. Non‑employee directors receive a mix of cash retainers and restricted stock, with increases to retainers and equity awards scheduled for 2026, and equity-based, performance‑linked incentives are emphasized for executives.